Volume 21, Issue 3

Search all International Journal of Clinical Oncology articles

June 2016

26 articles in this issue

Japan Society of Gynecologic Oncology guidelines 2013 for the treatment of uterine body neoplasms
Yasuhiko Ebina
Hidetaka Katabuchi
Hiroyuki Yoshikawa
Special Article 26 April 2016 Pages: 419 - 434
Japan Society of Gynecologic Oncology guidelines 2015 for the treatment of ovarian cancer including primary peritoneal cancer and fallopian tube cancer
Shinichi Komiyama
Hidetaka Katabuchi
Hiroyuki Yoshikawa
Special Article 03 May 2016 Pages: 435 - 446
PD-1/PD-L1 blockage in cancer treatment—from basic research to clinical application
Masaki Mandai
Introduction to Invited Review Articles 11 March 2016 Pages: 447 - 447
Basics of PD-1 in self-tolerance, infection, and cancer immunity
Shunsuke Chikuma
Invited Review Article 10 February 2016 Pages: 448 - 455
Anti-PD-L1/PD-1 immune therapies in ovarian cancer: basic mechanism and future clinical application
Masaki Mandai
Junzo Hamanishi
Ikuo Konishi
Invited Review Article 11 March 2016 Pages: 456 - 461
PD-1/PD-L1 blockade in cancer treatment: perspectives and issues
Junzo Hamanishi
Masaki Mandai
Ikuo Konishi
Invited Review Article Open access 22 February 2016 Pages: 462 - 473
A retrospective analysis on the utility and complications of upper arm ports in 433 cases at a single institute
Yukiko Mori
Satoshi Nagayama
Yoshiharu Sakai
Original Article Open access 27 October 2015 Pages: 474 - 482
Evaluation of the efficacy of palonosetron for prevention of chemotherapy-induced nausea and vomiting in patients with gastric cancer treated with S-1 plus cisplatin
Katsunobu Oyama
Sachio Fushida
Tetsuo Ohta
Original Article Open access 27 October 2015 Pages: 483 - 490
Efficacy of aprepitant for the prevention of chemotherapy-induced nausea and vomiting with a moderately emetogenic chemotherapy regimen: a multicenter, placebo-controlled, double-blind, randomized study in patients with gynecologic cancer receiving paclitaxel and carboplatin
Hideaki Yahata
Hiroaki Kobayashi
Kiyoko Kato
Original Article 10 December 2015 Pages: 491 - 497
Outcomes of very elderly patients with aggressive B-cell non-Hodgkin lymphoma treated with reduced-dose chemotherapy
Futoshi Iioka
Kiyotaka Izumi
Hitoshi Ohno
Original Article 13 October 2015 Pages: 498 - 505
Secondary cancers after a childhood cancer diagnosis: a nationwide hospital-based retrospective cohort study in Japan
Yasushi Ishida
Dongmei Qiu
Tatsuo Kuroda
Original Article 30 November 2015 Pages: 506 - 516
Health insurance status and survival among patients with head and neck cancer in Japan
Yukinori Takenaka
Toshimichi Yasui
Atsuhiko Uno
Original Article 07 November 2015 Pages: 517 - 522
Trimodality strategy for treating malignant pleural mesothelioma: results of a feasibility study of induction pemetrexed plus cisplatin followed by extrapleural pneumonectomy and postoperative hemithoracic radiation (Japan Mesothelioma Interest Group 0601 Trial)
Seiki Hasegawa
Morihito Okada
Takashi Nakano
Original Article Open access 17 November 2015 Pages: 523 - 530
Gemcitabine in patients previously treated with platinum-containing chemotherapy for refractory thymic carcinoma: radiographic assessment using the RECIST criteria and the ITMIG recommendations
Yusuke Okuma
Yukio Hosomi
Tsunekazu Hishima
Original Article 08 December 2015 Pages: 531 - 538
Prognostic impact of a single-nucleotide polymorphism near the CTSO gene in hormone receptor-positive breast cancer patients
Yukari Hato
Naoto Kondo
Tatsuya Toyama
Original Article 19 October 2015 Pages: 539 - 547
Stromal markers AKR1C1 and AKR1C2 are prognostic factors in primary human breast cancer
Antonia Wenners
Felix Hartmann
Maret Bauer
Original Article 14 November 2015 Pages: 548 - 556
Phase II multi-institutional prospective randomized trial comparing S-1 plus paclitaxel with paclitaxel alone as second-line chemotherapy in S-1 pretreated gastric cancer (CCOG0701)
Koki Nakanishi
Daisuke Kobayashi
Yasuhiro Kodera
Original Article 07 November 2015 Pages: 557 - 565
Multicenter randomized phase II clinical trial of oxaliplatin reintroduction as a third- or later-line therapy for metastatic colorectal cancer—biweekly versus standard triweekly XELOX (The ORION Study)
Chu Matsuda
Michitaka Honda
Hideyuki Mishima
Original Article 16 October 2015 Pages: 566 - 572
Proposal for selection criteria of secondary cytoreductive surgery in recurrent epithelial ovarian, tubal, and peritoneal cancers
Takeo Minaguchi
Toyomi Satoh
Hiroyuki Yoshikawa
Original Article 16 October 2015 Pages: 573 - 579
Human papillomavirus type-specific persistence and reappearance after successful conization in patients with cervical intraepithelial neoplasia
Akiko Kudoh
Shinya Sato
Tasuku Harada
Original Article 27 November 2015 Pages: 580 - 587
Characterization of mild and severe post-radical nephrectomy renal functional deterioration utilizing histopathological evaluation of non-neoplastic nephrectomized renal parenchyma
Takehiro Sejima
Tetsuya Yumioka
Atsushi Takenaka
Original Article 08 October 2015 Pages: 588 - 594
Preoperative predictive factors and further risk stratification of biochemical recurrence in clinically localized high-risk prostate cancer
Riu Hamada
Jun Nakashima
Masaaki Tachibana
Original Article 19 November 2015 Pages: 595 - 600
Erratum to: Preoperative predictive factors and further risk stratification of biochemical recurrence in clinically localized high-risk prostate cancer
Riu Hamada
Jun Nakashima
Masaaki Tachibana
Erratum 08 January 2016 Pages: 601 - 601
Age-based disparities in treatment and outcomes of retroperitoneal rhabdomyosarcoma
Mark A. Kashtan
Thejus T. Jayakrishnan
Kiran K. Turaga
Original Article 08 December 2015 Pages: 602 - 608
Incidence and severity of adverse events associated with re-irradiation for spine or pelvic bone metastases
Yasuhiro Hirano
Naoki Nakamura
Tetsuo Akimoto
Original Article 27 November 2015 Pages: 609 - 614
Sarcopenia as a predictor of major hepatectomy complications: a little addition
Umit Cintosun
Battal Altun
Letter to the Editor 26 November 2015 Pages: 615 - 615

Volume 21, Issue 3

Japan Society of Gynecologic Oncology guidelines 2013 for the treatment of uterine body neoplasms

Japan Society of Gynecologic Oncology guidelines 2015 for the treatment of ovarian cancer including primary peritoneal cancer and fallopian tube cancer

PD-1/PD-L1 blockage in cancer treatment—from basic research to clinical application

Basics of PD-1 in self-tolerance, infection, and cancer immunity

Anti-PD-L1/PD-1 immune therapies in ovarian cancer: basic mechanism and future clinical application

PD-1/PD-L1 blockade in cancer treatment: perspectives and issues

A retrospective analysis on the utility and complications of upper arm ports in 433 cases at a single institute

Evaluation of the efficacy of palonosetron for prevention of chemotherapy-induced nausea and vomiting in patients with gastric cancer treated with S-1 plus cisplatin

Efficacy of aprepitant for the prevention of chemotherapy-induced nausea and vomiting with a moderately emetogenic chemotherapy regimen: a multicenter, placebo-controlled, double-blind, randomized study in patients with gynecologic cancer receiving paclitaxel and carboplatin

Outcomes of very elderly patients with aggressive B-cell non-Hodgkin lymphoma treated with reduced-dose chemotherapy

Secondary cancers after a childhood cancer diagnosis: a nationwide hospital-based retrospective cohort study in Japan

Health insurance status and survival among patients with head and neck cancer in Japan

Trimodality strategy for treating malignant pleural mesothelioma: results of a feasibility study of induction pemetrexed plus cisplatin followed by extrapleural pneumonectomy and postoperative hemithoracic radiation (Japan Mesothelioma Interest Group 0601 Trial)

Gemcitabine in patients previously treated with platinum-containing chemotherapy for refractory thymic carcinoma: radiographic assessment using the RECIST criteria and the ITMIG recommendations

Prognostic impact of a single-nucleotide polymorphism near the CTSO gene in hormone receptor-positive breast cancer patients

Stromal markers AKR1C1 and AKR1C2 are prognostic factors in primary human breast cancer

Phase II multi-institutional prospective randomized trial comparing S-1 plus paclitaxel with paclitaxel alone as second-line chemotherapy in S-1 pretreated gastric cancer (CCOG0701)

Multicenter randomized phase II clinical trial of oxaliplatin reintroduction as a third- or later-line therapy for metastatic colorectal cancer—biweekly versus standard triweekly XELOX (The ORION Study)

Proposal for selection criteria of secondary cytoreductive surgery in recurrent epithelial ovarian, tubal, and peritoneal cancers

Human papillomavirus type-specific persistence and reappearance after successful conization in patients with cervical intraepithelial neoplasia

Characterization of mild and severe post-radical nephrectomy renal functional deterioration utilizing histopathological evaluation of non-neoplastic nephrectomized renal parenchyma

Preoperative predictive factors and further risk stratification of biochemical recurrence in clinically localized high-risk prostate cancer

Erratum to: Preoperative predictive factors and further risk stratification of biochemical recurrence in clinically localized high-risk prostate cancer

Age-based disparities in treatment and outcomes of retroperitoneal rhabdomyosarcoma

Incidence and severity of adverse events associated with re-irradiation for spine or pelvic bone metastases

Sarcopenia as a predictor of major hepatectomy complications: a little addition

Navigation